Correction to: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer (npj Breast Cancer
- Autori: Fabi A.; Carbognin L.; Botticelli A.; Paris I.; Fuso P.; Savastano M.C.; La Verde N.; Strina C.; Pedersini R.; Guarino S.; Curigliano G.; Criscitiello C.; Raffaele M.; Beano A.; Franco A.; Valerio M.R.; Verderame F.; Fontana A.; Haspinger E.R.; Caldara A.; Di Leone A.; Tortora G.; Giannarelli D.; Scambia G.
- Anno di pubblicazione: 2024
- Tipologia: Articolo in rivista
- OA Link: http://hdl.handle.net/10447/626674
Abstract
Nature Portfolio 1 13 0 2024 Springer Nature Limited 2024 No Unnumbered 2024 1 24 0 0 Regular NonStandardArchiveJournal Unnumbered OpenChoice OpenAccess OpenAccess OpenAccess OpenAccess OpenAccess OpenAccess false BodyRef/PDF/41523_2024_Article_619.pdf Typeset OnlinePDF Regular Erratum Biomedicine Biomedicine, general Cancer Research Oncology Human Genetics Cell Biology Biomedical and Life Sciences true Correction to: npj Breast Cancerhttps://doi.org/10.1038/s41523-023-00579-2, published online 08 September 2023 In this article the author name Paola Fuso was incorrectly written as Paolo Fuso. The original article has been corrected.